Cost-Effectiveness of Early Versus Delayed Functional Restoration for Chronic Disabling Occupational Musculoskeletal Disorders

被引:0
作者
Brian R. Theodore
Tom G. Mayer
Robert J. Gatchel
机构
[1] PRIDE Research Foundation,Department of Anesthesiology and Pain Medicine
[2] University of Washington,Department of Orthopedic Surgery
[3] The University of Texas Southwestern Medical Center at Dallas,Department of Psychology, College of Science
[4] The University of Texas at Arlington,Department of Anesthesiology and Pain Management
[5] The University of Texas Southwestern Medical Center,undefined
来源
Journal of Occupational Rehabilitation | 2015年 / 25卷
关键词
Chronic pain; Disability; Musculoskeletal disorders; Functional restoration; Socioeconomic outcomes; Cost-effectiveness analysis;
D O I
暂无
中图分类号
学科分类号
摘要
Purpose Despite extensive evidence for the treatment effectiveness of interdisciplinary functional restoration (FR) for chronic disabling occupational musculoskeletal disorders (CDOMD), there is little documentation on the cost-effectiveness of early rehabilitation using FR. Methods A total of 1,119 CDOMD patients were classified according to duration of disability on FR entry, corresponding to early rehabilitation (ER: 4–8 months of disability, N = 373), intermediate duration (ID: 9–18 months, N = 373), and delayed rehabilitation (DR: >18 months, N = 373). Groups were matched on sex, age, ethnicity, and injured musculoskeletal region. One-year post-rehabilitation outcomes included return-to-work, work retention and healthcare utilization. Economic analyses included a cost-effectiveness analysis of the FR program, and estimation of the total cost-of-illness. Results At 1-year post-rehabilitation, all groups were comparable on return-to-work (overall 88 %), work retention (overall 80 %), and additional healthcare utilization (overall, 2.2 % of patients received re-operations/new surgeries, 2 visits to new healthcare provider). Savings of up to 64 % in medical costs, and up to 80 % in disability benefits and productivity losses was associated with the ER group. The cost of rehabilitation was also up to 56 % lower when administered early. Overall, ER resulted in estimated cost savings of up to 72 % (or almost $170,000 per claim). Conclusions Duration of disability does not negatively impact objective work or healthcare utilization outcomes following interdisciplinary FR. However, early rehabilitation is more likely to be a cost-effective solution compared to cases that progress >8 months and receiving FR as a treatment of “last resort”.
引用
收藏
页码:303 / 315
页数:12
相关论文
共 43 条
[31]   Cost-effectiveness of Mindfulness-based Stress Reduction Versus Cognitive Behavioral Therapy or Usual Care Among Adults With Chronic Low Back Pain [J].
Herman, Patricia M. ;
Anderson, Melissa L. ;
Sherman, Karen J. ;
Balderson, Benjamin H. ;
Turner, Judith A. ;
Cherkin, Daniel C. .
SPINE, 2017, 42 (20) :1511-1520
[32]   Cooled versus conventional radiofrequency treatment of the genicular nerves for chronic knee pain: 12-month and cost-effectiveness results from the multicenter COCOGEN trial [J].
Belba, Amy ;
Vanneste, Thibaut ;
Kallewaard, Jan Willem ;
van Kuijk, Sander M. J. ;
Gelissen, Marloes ;
Emans, Peter ;
Bellemans, Johan ;
Smeets, Kristof ;
Van Boxem, Koen ;
Sommer, Micha ;
Kimman, Merel ;
Van Zundert, Jan .
REGIONAL ANESTHESIA AND PAIN MEDICINE, 2024, :36-45
[33]   Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer [J].
Hui Sun ;
Huishan Wang ;
Yan Wei ;
Haiyin Wang ;
Chunlin Jin ;
Yingyao Chen .
Cost Effectiveness and Resource Allocation, 21
[34]   Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer [J].
Sun, Hui ;
Wang, Huishan ;
Wei, Yan ;
Wang, Haiyin ;
Jin, Chunlin ;
Chen, Yingyao .
COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2023, 21 (01)
[35]   IMPROVED PHYSICAL PERFORMANCE OUTCOMES AFTER FUNCTIONAL RESTORATION TREATMENT IN PATIENTS WITH CHRONIC LOW-BACK-PAIN - EARLY VERSUS RECENT TRAINING RESULTS [J].
KOHLES, S ;
BARNES, D ;
GATCHEL, RJ ;
MAYER, TG .
SPINE, 1990, 15 (12) :1321-1324
[36]   Study protocol randomised controlled trial comparison of cost-utility and cost-effectiveness of a face-to-face rehabilitation programme versus a telemedicine programme in the treatment of patients with chronic low back pain [J].
Castro-Sanchez, Adelaida M. ;
Mataran-Penarrocha, Guillermo Adolfo ;
Gomez-Garcia, Silvia ;
Garcia-Lopez, Hector ;
Andronis, Lazaro ;
Albornoz-Cabello, Manuel ;
Lara Palomo, Inmaculada C. .
BMJ OPEN, 2020, 10 (12)
[37]   Cost-Effectiveness of Venetoclax Plus Obinutuzumab Versus Chlorambucil Plus Obinutuzumab for the First-Line Treatment of Adult Patients With Chronic Lymphocytic Leukemia: An Extended Societal View [J].
Do, Ngoc ;
Thielen, Frederick W. .
VALUE IN HEALTH, 2023, 26 (04) :477-486
[38]   Cost-Effectiveness of Drug-Coated Balloon Angioplasty Versus Conventional Balloon Angioplasty for Treating Below-the-Knee Arteries in Chronic Limb-Threatening Ischemia: The SINGA-PACLI Trial [J].
Nirmali Sivapragasam ;
David B. Matchar ;
Kun Da Zhuang ;
Ankur Patel ;
Uei Pua ;
Hlaing Hlaing Win ;
Sivanathan Chandramohan ;
Nanda Venkatanarasimha ;
Jasmine M. E. Chua ;
Glenn Wei Leong Tan ;
Farah G. Irani ;
Sum Leong ;
Kiang Hiong Tay ;
Tze Tec Chong ;
Bien Soo Tan .
CardioVascular and Interventional Radiology, 2022, 45 :1663-1669
[39]   Cost-Effectiveness of Drug-Coated Balloon Angioplasty Versus Conventional Balloon Angioplasty for Treating Below-the-Knee Arteries in Chronic Limb-Threatening Ischemia: The SINGA-PACLI Trial [J].
Sivapragasam, Nirmali ;
Matchar, David B. ;
Zhuang, Kun Da ;
Patel, Ankur ;
Pua, Uei ;
Win, Hlaing Hlaing ;
Chandramohan, Sivanathan ;
Venkatanarasimha, Nanda ;
Chua, Jasmine M. E. ;
Tan, Glenn Wei Leong ;
Irani, Farah G. ;
Leong, Sum ;
Tay, Kiang Hiong ;
Chong, Tze Tec ;
Tan, Bien Soo .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2022, 45 (11) :1663-1669
[40]   Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1 [J].
Escudero-Vilaplana, Vicente ;
Collado-Borrell, Roberto ;
De Castro, Javier ;
Insa, Amelia ;
Martinez, Alex ;
Fernandez, Elena ;
Sullivan, Ivana ;
Flores, Andres ;
Arrabal, Natalia ;
Carcedo, David ;
Manzaneque, Alba .
JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) :445-453